Tag Archives: PUBLIC MEETING

FDA Commissioner Gottlieb Issues Statement On Advancing the Science and Regulation of Live Microbiome-Based Products

FDA Commissioner Scott Gottlieb, MD, issued a statement on August 16 regarding the role of microorganisms on health.  Dr. Gottlieb provided background on the use and regulatory status of microorganisms. Also in his statement, Commissioner Gottlieb provided the underlying rationale for his statement via the example of probiotics administered to premature infants as a preventive … Continue Reading

FDA Holds Public Meeting on Comprehensive, Multi-Year Nutrition Innovation Strategy

In a March 29 speech at the National Food Policy Conference, FDA Comissioner Dr. Scott Gottlieb announced the Nutrition Innovation Strategy (NIS).  Commissioner Gottlieb hopes to improve public health by: (1) empowering consumers to make better and more informed decisions about their diets, (2) encourage the development of healthier foods, and (3) expand the use … Continue Reading

FDA Announces Public Meeting to Discuss Nutrition Innovation Strategy

In March, FDA Commissioner Dr. Scott Gottlieb announced a comprehensive, multi-year FDA Nutrition Innovation Strategy, which aims to modernize FDA’s approach to nutrition, help reduce the burden of chronic disease that stems from poor nutrition, and remove barriers to industry innovation. On June 27, 2018, FDA published a notice of public meeting and a request … Continue Reading

FDA Announces November 2017 Public Meetings Concerning Its Agricultural Biotechnology Education and Outreach Initiative

On April 18, 2017, as the House Committee on Appropriations marked up the FY 2017 agriculture spending bill, more than 65 agriculture and food industry groups sent a letter to Congress urging Congress to appropriate $3 million to FDA to fund a joint FDA/USDA consumer outreach program to educate consumers about foods produced with genetically … Continue Reading

FDA Announces October Meeting on Pre-DSHEA List

Manufacturers or distributors of new dietary ingredients (NDIs) must submit a pre-market notification called a new dietary ingredient notification (NDIN) to FDA at least 75 days before marketing a dietary supplement that contains an NDI (i.e., one not marketed in the U.S. prior to October 15, 1994).  On August 12, 2016, FDA issued a revised Draft Guidance on … Continue Reading

FSMA Implementation Update: Public Meeting

FDA holding a public meeting on FSMA implementation strategy. As the food industry is well aware, implementation of the FDA Food Safety Modernization Act (FSMA) is a work in progress.  FDA has issued several major proposed rules (e.g., hazard analysis and risk-based preventive control provisions, produce safety provisions) that are due to be finalized later … Continue Reading
LexBlog

We and our analytics and advertising providers may use cookies and similar technologies to enhance the browsing experience, facilitate sharing of content, and generate statistics about use of the website. For more information or to change your preferences, click here.

I Agree